Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin/Topotecan vs Paclitaxel/Carboplatin in Advanced Ovarian Cancer
NCT00028743Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Aug 2001
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of topotecan in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by Canadian Cancer Trials Group. Primary endpoint: Progression Free Survival. Started Aug 2001; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00028743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028743.